RWTH Aachen University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Aachen Germany (1870)

Organization Overview

First Clinical Trial
1998
NCT00593801
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Aachen University | Aachen University Hospital | Cardiology, RWTH University Hospital Aachen | Clinic for Pediatrics and Youth Medicine, University Hospital of RWTH Aachen University | Department of Anesthesiology, University Hospital Aachen | Department of Anesthesiology, University Hospital Aachen, Germany | Department of Gynecology and Obstetrics | Department of Internal Medicine III, University Hospital Aachen | Department of Internal Medicine I, RWTH Aachen University Hospital | Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital Aachen | Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital RWTH Aachen, Germany | Dep. of Thoracic and Cardiovascular Surgery, University Hospital RWTH Aachen | Klinik für Gastroenterologie, Stoffwechselerkrankungen und Internistische Intensivmedizin (Med. Klinik III), Uniklinik RWTH Aachen | Klinikum Krefeld | Medical Clinic II, University Hospital Aachen | RTWH Aachen University | RWTH Aachen University | RWTH Aachen University Departement of Cardiology, Pulmonology and Vascular Medicine | RWTH Aachen University, Department of Dermatology and Allergology | RWTH Aachen University Hospital | RWTH University Aachen; Department of Anesthesiology | RWTH University Clinic Aachen | RWTH University Hospital MK4 | Surgical Intensive Care - Adults, University Hospital Aachen | Tao OUYANG | Uniklinik RWTH Aachen | Uniklinik RWTH Aachen, Med. Klinik III | Universitatsklinikum Aachen | Universitatsklinikum Aachen Kinderklinik | Universitiy hospital RWTH Aachen, Department of Neurology | University Aachen | Universityclinic of the RWTH Aachen | University Clinic of the RWTH Aachen | University Hospital, Aachen | University Hospital Aachen - Germany | University Hospital of RWTH Aachen -Department of Medicine II, Nephrology and Clinical Immunology | University Hospital of the RWTH Aachen | University Hospital RWTH Aachen | University Hospital RWTH Aachen, Department for Anesthesia | University of Aachen | University of Aachen Medical Faculty | University RWTH Aachen | Univ.-Prof. Dr. med. F. Kiessling | urological hospital of Maria Hilf Krankenhaus Krefeld

Active Ingredients

Drugs in Phase 4 Trials (30)

atomoxetine (strattera) (1 trial)

cyclophosphamide (cytoxan) (3 trials)

desflurane (suprane) (2 trials)

entecavir (baraclude) (1 trial)

epirubicin (ellence) (1 trial)

fluorouracil (efudex) (1 trial)

haloperidol (haldol) (2 trials)

isoflurane (forane) (2 trials)

lorazepam (ativan) (1 trial)

midazolam (versed) (2 trials)

n-methyllorazepam (1 trial)

ondansetron (zofran) (1 trial)

phenprocoumon (liquamar) (1 trial)

pipamperone hydrochloride (1 trial)

prothipendyl hydrochloride (1 trial)

quetiapine (seroquel) (3 trials)

risperidone (risperdal) (2 trials)

rivaroxaban (xarelto) (1 trial)

sertindole (1 trial)

sevoflurane (ultane) (5 trials)

sodium chloride (2 trials)

sulpiride (1 trial)

telmisartan (micardis) (1 trial)

thioridazine (mellaril) (1 trial)

urea (2 trials)

vinorelbine (navelbine) (1 trial)

xenon-129 (1 trial)

xenon xe-133 (6 trials)

ziprasidone (geodon) (1 trial)

zuclopenthixol hydrochloride (1 trial)

Drugs in Phase 3 Trials (25)

azathioprine (imuran) (1 trial)

batefenterol (1 trial)

calcium (1 trial)

calcium carbonate (1 trial)

ferric carboxymaltose (Injectafer) (1 trial)

idursulfase (elaprase) (1 trial)

linagliptin (tradjenta) (2 trials)

liraglutide (victoza) (1 trial)

magnesium carbonate (1 trial)

menaquinone (1 trial)

mesalamine (rowasa) (1 trial)

methylprednisolone (medrol) (2 trials)

octenidine (1 trial)

paclitaxel (taxol) (2 trials)

pantothenic acid (1 trial)

phytonadione (konakion) (1 trial)

polihexanide (1 trial)

prednisone (meticorten) (1 trial)

propofol (diprivan) (1 trial)

rituximab (rituxan) (1 trial)

ruxolitinib (jakafi) (1 trial)

sodium selenium oxide (2 trials)

sulfur hexafluoride lipid-type a microspheres (Lumason) (1 trial)

tacrolimus (prograf) (1 trial)

vitamin k (1 trial)

Drugs in Phase 2 Trials (19)

bosutinib (bosulif) (1 trial)

cabazitaxel (jevtana kit) (1 trial)

capecitabine (xeloda) (1 trial)

carboplatin (paraplatin) (1 trial)

cocoa bean (1 trial)

dimethyl fumarate (tecfidera) (1 trial)

empagliflozin (jardiance) (2 trials)

etoposide (vepesid) (1 trial)

flavanoids (1 trial)

irinotecan (Camptosar) (1 trial)

nicotinamide (1 trial)

oxytocin (syntocinon) (2 trials)

pentaglobin (1 trial)

ponatinib (iclusig) (1 trial)

rifaximin (xifaxan) (1 trial)

snf472 (1 trial)

sunitinib (sutent) (1 trial)

tipiracil (lonsurf) (1 trial)

trifluridine (viroptic) (1 trial)

Drugs in Phase 1 Trials (1)

naltrexone (revia) (1 trial)

Drugs in Other Trials (7)

chlorhexidine (hibitane) (1 trial)

clobetasol (dermovate) (1 trial)

darbepoetin beta (1 trial)

escitalopram (lexapro) (1 trial)

levosimendan (1 trial)

vitamin d3 (1 trial)

vitamin k2 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 1)

Anemia, Iron-Deficiency (Phase 3)

Aortic Valve Stenosis (Phase 3)

Ataxia (Phase 2)

Atrial Fibrillation (Phase 4)

Breast Neoplasms (Phase 4)

Calcinosis (Phase 4)

Calciphylaxis (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Cardiovascular Diseases (Phase 3)

Cerebellar Ataxia (Phase 2)

Cholangiocarcinoma (Phase 2)

Coronary Disease (Phase 3)

Delirium (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Embolism (Phase 4)

Fibrosis (Phase 4)

Friedreich Ataxia (Phase 2)

Gastrointestinal Stromal Tumors (Phase 2)

Glomerulonephritis, IGA (Phase 3)

Glomerulonephritis, Membranous (Phase 3)

Heart Diseases (Phase 3)

Heart Failure (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hip Fractures (Phase 2)

Hyperphosphatemia (Phase 3)

Hypertension (Phase 4)

Hypothermia (Phase 2)

Inflammation (Phase 3)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Liver Cirrhosis (Phase 4)

Liver Diseases (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Cutaneous (Phase 2)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Multiple Myeloma (Phase 2)

Myocardial Reperfusion Injury (Phase 4)

Nausea (Phase 4)

Neoplasm Metastasis (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Peripheral Arterial Disease (Phase 2)

Peritonitis (Phase 2)

Polycythemia (Phase 3)

Polycythemia Vera (Phase 3)

Postoperative Nausea and Vomiting (Phase 4)

Pulmonary Embolism (Phase 4)

Renal Insufficiency, Chronic (Phase 3)

Reperfusion Injury (Phase 4)

Respiratory Aspiration (Phase 2)

Schizophrenia (Phase 4)

Syndrome (Phase 3)

Thrombocythemia, Essential (Phase 3)

Thrombocytosis (Phase 3)

Vascular Calcification (Phase 3)

Ventricular Dysfunction (Phase 3)

Ventricular Dysfunction, Left (Phase 3)

Vomiting (Phase 4)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 69
  • # of Trial APIs: 82